Patent · US Active

5-alkynyl-pyrimidines

US9321771B2 · kind B2 · utility

0Cited by

3References

2Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Siegfried Schneider · Wien, AT
Dirk Kessler · Wien, AT
Lars Van Der Veen · Wien, AT
Tobias Wunberg · Mödling, AT

Key dates

Filing date	Nov 22, 2013
Grant date	Apr 26, 2016
Priority date	—
Expiry date	Nov 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1)whereinR1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.